FGFR2 and intrahepatic cholangiocarcinoma: Consistent with previous studies, FGFR2 fusion partners identified in Chinese patients with ICC in our study are diverse and mostly individual‐specific; 26 fusion partners were identified in Chinese patients as compared with up to 128 in other populations.31